Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Use of medicine composition in preparation of medicines treating qi-stagnation blood-stasis type chloasma

A technology of qi stagnation and blood stasis type and composition, which is applied in the field of preparing medicines for treating chloasma of qi stagnation and blood stasis type. The effect of drug stability of the preparation

Inactive Publication Date: 2016-03-16
GUANGDONG JUZHICHENG TECH
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The invention has the advantages of regulating qi and promoting blood circulation, removing blood stasis and eliminating spots, quick onset, high efficiency, definite curative effect, short course of treatment, no toxic and side effects, and low price, but the composition of the drug is complex and the production process is cumbersome

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Use of medicine composition in preparation of medicines treating qi-stagnation blood-stasis type chloasma
  • Use of medicine composition in preparation of medicines treating qi-stagnation blood-stasis type chloasma

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] The pharmaceutical composition is prepared from the following raw materials in parts by weight: 10 parts of Moringa leaves, 9 parts of black trigonum, 8 parts of motherwort, 8 parts of curcuma, 6 parts of lily, 6 parts of scallion, 5 parts of hawthorn, bergamot 5 parts, 3 parts of fresh rehmannia, 3 parts of mulberry, 3 parts of jujube, 3 parts of ginseng and 2 parts of licorice.

[0035] The preparation method is as follows:

[0036] S1: Take leaves of Moringa oleifera oleifera, wash, dry, crush, pass through a 150-mesh sieve, add 10 times the amount of ethanol with a volume fraction of 75% of the total amount of medicinal materials, and then add 2% of the total amount of medicinal materials Helicase, soak at 38°C Extract for 1 hour, then reflux extraction at 85°C for 5 hours, filter, and concentrate the filtrate under reduced pressure to an extract with a relative density of 1.20 at 60°C to obtain Extract A;

[0037]S2: Take black trigonum, motherwort, turmeric, lily...

Embodiment 2

[0041] The pharmaceutical composition is prepared from the following preparation raw materials in parts by weight: 15 parts of Moringa leaves, 12 parts of black trigonum, 10 parts of motherwort, 10 parts of curcuma, 8 parts of lily, 8 parts of scallion, 7 parts of hawthorn, bergamot 7 parts, 6 parts of fresh rehmannia, 6 parts of mulberry, 6 parts of jujube, 6 parts of ginseng and 5 parts of licorice.

[0042] The preparation method is as in Example 1.

Embodiment 3

[0044] The pharmaceutical composition is prepared from the following raw materials in parts by weight: 25 parts of Moringa leaves, 20 parts of black trigonum, 15 parts of motherwort, 12 parts of curcuma, 10 parts of lily, 10 parts of scallion, 10 parts of hawthorn, bergamot 10 parts, 9 parts of fresh rehmannia, 9 parts of mulberry, 9 parts of jujube, 9 parts of ginseng and 10 parts of licorice.

[0045] The preparation method is as in Example 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of medicines and relates to a use of a medicine composition in preparation of medicines treating qi-stagnation blood-stasis type chloasma. The composition is prepared from following raw materials by weight: 10-25 parts of horseradish tree leaves, 9-20 parts of bur-reed, 8-15 parts of motherwort herb, 8-12 parts of turmeric root tuber, 6-10 parts of lily bulb, 6-10 parts of longstamen onion bulb, 5-10 parts of hawthorn fruit, 5-10 parts of finger citron, 3-9 parts of fresh rehmannia root, 3-9 parts of mulberry fruit, 3-9 parts of Chinese date, 3-9 parts of ginseng and 2-10 parts of liquorice root. The composition has effects of promoting blood circulation to remove stasis, soothing the liver, regulating qi and regulating qi activity. The composition is advantaged by being definite in curative effects, safe and reliable when being used for treating the qi-stagnation blood-stasis type chloasma.

Description

technical field [0001] The invention belongs to the field of medicines, and relates to the application of a medicine composition in the preparation of medicines for treating chloasma of Qi stagnation and blood stasis type. Background technique [0002] With the development of society and the continuous improvement of material level, people's pursuit of beauty is also gradually strengthened, especially women's awareness of beauty has been significantly enhanced, and chloasma is one of the current loss of appearance diseases, although skin lesions can not bring pain and itching to patients Discomfort, but it seriously affects the appearance, and often brings certain social pressure and psychological pressure to the patient. This is a problem that both the medical and cosmetology circles are very concerned about. Traditional Chinese medicine believes that chloasma is mostly closely related to the liver, spleen, and kidneys, and the main pathogenesis is that Qi and blood cannot ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/9066A61P17/00
CPCA61K36/9066A61K36/185A61K36/258A61K36/484A61K36/533A61K36/605A61K36/725A61K36/734A61K36/752A61K36/804A61K36/8962A61K36/8967A61K36/902A61K2236/19A61K2236/331A61K2236/333A61K2236/39A61K2236/51A61K2236/53
Inventor 邓凤桂
Owner GUANGDONG JUZHICHENG TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com